Gerald J. Holtmann

Gerald J. Holtmann's AcademicInfluence.com Rankings

Gerald J. Holtmann

Biology

#10281

World Rank

#13594

Historical Rank

Microbiology

#574

World Rank

#639

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Gerald J. Holtmann Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gerald J. Holtmann's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Immune activation in patients with irritable bowel syndrome. (2007) (497)
AGA technical review: Evaluation of dyspepsia ☆ ☆☆ (1998) (472)
Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis. (2018) (312)
The ion channel TRPA1 is required for normal mechanosensation and is modulated by algesic stimuli. (2009) (250)
Selective role for TRPV4 ion channels in visceral sensory pathways. (2008) (234)
A placebo-controlled trial of itopride in functional dyspepsia. (2006) (217)
Prokinetics in Patients with Gastroparesis: A Systematic Analysis (1999) (214)
Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. (1999) (213)
[Maintaining remission of ulcerative colitis with the probiotic Escherichia Coli Nissle 1917 is as effective as with standard mesalazine]. (2006) (211)
[Irritable bowel syndrome: German consensus guidelines on definition, pathophysiology and management]. (2011) (198)
G-protein β3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia 1 ☆ (2004) (196)
Treatment of irritable bowel syndrome with herbal preparations: results of a double‐blind, randomized, placebo‐controlled, multi‐centre trial (2004) (189)
Asia‐Pacific consensus on the management of gastroesophageal reflux disease: Update (2007) (186)
Pathophysiology of irritable bowel syndrome. (2016) (184)
Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: A literature review (2007) (177)
MR colonography with barium-based fecal tagging: initial clinical experience. (2002) (160)
Sensory neuro-immune interactions differ between Irritable Bowel Syndrome subtypes (2012) (158)
Functional dyspepsia (2017) (152)
Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia (1998) (149)
G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. (2004) (146)
Small Bowel Homing T Cells Are Associated With Symptoms and Delayed Gastric Emptying in Functional Dyspepsia (2011) (145)
Dyspepsia and the microbiome: time to focus on the small intestine (2016) (142)
The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data (2019) (131)
Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus (2016) (128)
Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis? (1997) (122)
Determinants of health-related quality of life in patients with chronic liver diseases. (2004) (121)
Functional Dyspepsia Is Associated With a Greater Symptomatic Response to Fat But Not Carbohydrate, Increased Fasting and Postprandial CCK, and Diminished PYY (2008) (120)
Antidepressants and inflammatory bowel disease: a systematic review (2006) (118)
Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six‐week placebo‐controlled, double‐blind, multicentre trial (2003) (118)
Is there an association between hospital accreditation and patient satisfaction with hospital care? A survey of 37,000 patients treated by 73 hospitals. (2011) (117)
New algorithm for the treatment of gastro‐oesophageal reflux disease (2007) (112)
Real time high resolution magnetic resonance imaging for the assessment of gastric motility disorders (2004) (112)
AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. (1998) (112)
Relationship between symptoms and dietary patterns in patients with functional dyspepsia. (2009) (111)
Treatment of Functional Dyspepsia with a Herbal Preparation (2004) (109)
Effects of Iberogast® on Proximal Gastric Volume, Antropyloroduodenal Motility and Gastric Emptying in Healthy Men (2007) (103)
A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease. (2012) (101)
Review article: associations between Helicobacter pylori and obesity ‐ an ecological study (2014) (101)
Pathophysiology of Functional Gastrointestinal Disorders: A Holistic Overview (2018) (100)
Autism-related dietary preferences mediate autism-gut microbiome associations (2021) (98)
Dyspepsia in consulters and non‐consulters: prevalence, health‐care seeking behaviour and risk factors (1994) (98)
Clinical trial guidelines for pharmacological treatment of irritable bowel syndrome (2003) (98)
A randomized placebo‐controlled trial on the effects of Menthacarin, a proprietary peppermint‐ and caraway‐oil‐preparation, on symptoms and quality of life in patients with functional dyspepsia (2017) (97)
Severity of mucosal inflammation as a predictor for alterations of visceral sensory function in a rat model (2006) (94)
Mood and Anxiety Disorders Precede Development of Functional Gastrointestinal Disorders in Patients but Not in the Population (2017) (94)
Altered postprandial motility in chronic pancreatitis: role of malabsorption. (1997) (93)
MR colonography without colonic cleansing: a new strategy to improve patient acceptance. (2001) (89)
A randomized placebo‐controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia (2002) (87)
Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors (2018) (84)
Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study (2000) (84)
Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls (2000) (80)
Increased visceral sensitivity to capsaicin after DSS-induced colitis in mice: spinal cord c-Fos expression and behavior. (2007) (79)
Impaired small intestinal peristaltic reflexes and sensory thresholds are independent functional disturbances in patients with chronic unexplained dyspepsia. (1996) (79)
Functional gastrointestinal disorders in inflammatory bowel disease: Impact on quality of life and psychological status (2011) (78)
Long-Term Effects of Transient Chemically Induced Colitis on the Visceromotor Response to Mechanical Colorectal Distension (2002) (78)
Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy? (2007) (78)
Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia (2005) (76)
Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies. (2020) (76)
Stress and Gastrointestinal Motility in Humans: A Review of the Literature (1991) (75)
Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5. (2006) (75)
Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters (2004) (75)
Are There Alterations of Neuroendocrine and Cellular Immune Responses to Nutrients in Women with Irritable Bowel Syndrome? (2004) (75)
Psychological problems in gastroenterology outpatients: A South Australian experience. Psychological co-morbidity in IBD, IBS and hepatitis C (2008) (75)
A randomized, double‐blind, comparative study of standard‐dose rabeprazole and high‐dose omeprazole in gastro‐oesophageal reflux disease (2002) (70)
MR colonography in patients with incomplete conventional colonoscopy. (2005) (70)
Reflux disease: the disorder of the third millennium. (2001) (69)
Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. (2016) (69)
Challenging the holy grail of hospital accreditation: A cross sectional study of inpatient satisfaction in the field of cardiology (2010) (65)
Does psychological status influence clinical outcomes in patients with inflammatory bowel disease (IBD) and other chronic gastroenterological diseases: An observational cohort prospective study (2008) (64)
The effect of functional gastrointestinal disorders on psychological comorbidity and quality of life in patients with inflammatory bowel disease (2008) (60)
Prevalence of Unexplained Upper Abdominal Symptoms in Patients with Migraine (2006) (59)
Influence of cigarette smoking on the human duodenal mucosa-associated microbiota (2018) (58)
A genetic association study of 5‐HTT LPR and GNβ3 C825T polymorphisms with irritable bowel syndrome (2007) (57)
"It doesn't do any harm, but patients feel better": a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease (2007) (56)
Characterisation of the gastrointestinal mucosa‐associated microbiota: a novel technique to prevent cross‐contamination during endoscopic procedures (2016) (55)
Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology (2015) (55)
Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress (2019) (54)
Systematic review with meta‐analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease (2019) (53)
Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients (2008) (51)
Public Speaking Stress-Induced Neuroendocrine Responses and Circulating Immune Cell Redistribution in Irritable Bowel Syndrome (2006) (51)
Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin? (2002) (51)
Nonischemic chest pain induced by coronary interventions: a prospective study comparing coronary angioplasty and stent implantation. (1998) (50)
TRPV1-expressing sensory fibres and IBS: links with immune function (2009) (49)
Antibody Response to Specific H. pylori Antigens in Functional Dyspepsia, Duodenal Ulcer Disease, and Health (1998) (49)
Impairment of health‐related quality of life in functional dyspepsia and chronic liver disease: the influence of depression and anxiety (2008) (49)
Is there any association between disturbed gastrointestinal visceromotor and sensory function and impaired quality of life in functional dyspepsia? (2010) (47)
GERD 2003 – A Consensus on the Way Ahead (2003) (47)
Nomenclature of dyspepsia, dyspepsia subgroups and functional dyspepsia: clarifying the concepts. (1998) (47)
Un‐promoted issues in inflammatory bowel disease: opportunities to optimize care (2010) (47)
Clinical Presentation and Personality Factors Are Predictors of the Response to Treatment in Patients with Functional Dyspepsia: A Randomized, Double-Blind Placebo-Controlled Crossover Study (2004) (47)
Systematic Review and Meta-Analysis: Prevalence of Small Intestinal Bacterial Overgrowth in Chronic Liver Disease (2017) (44)
Review article: oesophageal complications and consequences of persistent gastro‐oesophageal reflux disease (2004) (44)
Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation (2005) (43)
Immune derived opioidergic inhibition of viscerosensory afferents is decreased in Irritable Bowel Syndrome patients (2014) (42)
An Integrated Model of Care for Inflammatory Bowel Disease Sufferers in Australia: Development and the Effects of Its Implementation (2012) (42)
Anti-TNFα therapy in IBD alters brain activity reflecting visceral sensory function and cognitive-affective biases (2018) (41)
Mechanisms of Disease: genetics of functional gastrointestinal disorders—searching the genes that matter (2007) (41)
Low ambient temperatures are associated with more rapid spread of COVID-19 in the early phase of the endemic (2020) (41)
A combination of peppermint oil and caraway oil attenuates the post-inflammatory visceral hyperalgesia in a rat model (2006) (40)
The stomach-brain axis. (2014) (40)
Effects of Antibiotic Therapy in Primary Sclerosing Cholangitis with and without Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis (2019) (39)
Effect of E. coli Nissle 1917 on post‐inflammatory visceral sensory function in a rat model (2005) (39)
Dyspepsia in healthy blood donors (1994) (38)
Systematic review: health‐related quality of life (HRQOL) questionnaires in gastro‐oesophageal reflux disease (2008) (38)
Review article: the patient with gastro‐oesophageal reflux disease – lifestyle advice and medication (2004) (38)
Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework (2020) (37)
Pancreatic enzymes in chronic pancreatitis (1994) (37)
Capsaicin-Sensitive Nerve Fibres Induce Epithelial Cell Proliferation, Inflammatory Cell Immigration and Transforming Growth Factor-alpha Expression in the Rat Colonic Mucosa In Vivo (2002) (36)
Visceral pain and public speaking stress: Neuroendocrine and immune cell responses in healthy subjects (2006) (36)
Functional gastroduodenal disorders. (2006) (36)
The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical Setting (2017) (35)
The rise and demise of plastic shopping bags in Chile – Broad and informal coalition supporting ban as a first step to reduce single-use plastics (2020) (35)
Influence of stress on the healing and relapse of duodenal ulcers. A prospective, multicenter trial of 2109 patients with recurrent duodenal ulceration treated with ranitidine. RUDER Study Group. (1992) (35)
Herbal medicines for the treatment of functional and inflammatory bowel disorders. (2015) (34)
Effects of a fixed combination of peppermint oil and caraway oil on symptoms and quality of life in patients suffering from functional dyspepsia. (2003) (34)
Adverse clinical phenotype in inflammatory bowel disease: A cross sectional study identifying factors potentially amenable to change (2010) (34)
Do we know what patients want? The doctor-patient communication gap in functional gastrointestinal disorders. (2009) (34)
Differential effects of acute mental stress on interdigestive secretion of gastric acid, pancreatic enzymes, and gastroduodenal motility (1989) (33)
Real‐time high‐resolution MRI for the assessment of gastric motility: Pre‐ and postpharmacological stimuli (2004) (32)
Link Between Celiac Disease and Inflammatory Bowel Disease (2019) (32)
The burden of inpatient costs in inflammatory bowel disease and opportunities to optimize care: a single metropolitan Australian center experience. (2010) (32)
[Guidelines of the German Society of Digestive and Metabolic Diseases for treatment of dyspepsia]. (2001) (31)
[Consensus report: irritable bowel syndrome--definition, differential diagnosis, pathophysiology and therapeutic possibilities. Consensus of the German Society of Digestive and Metabolic Diseases]. (1999) (31)
Management of Reflux Symptoms with Over-the-Counter Proton Pump Inhibitors: Issues and Proposed Guidelines (2009) (31)
A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndrome. (2007) (30)
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. (2021) (30)
Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten‐free diet (2020) (29)
Psychological stress and the severity of post‐inflammatory visceral hyperalgesia (2007) (29)
Effect of transient chemically induced colitis on the visceromotor response to mechanical colorectal distension (2002) (28)
Proton-pump inhibitors or H2-receptor antagonists for Helicobacter pylori eradication—a meta-analysis (1996) (28)
Review article: From gastrin to gastro‐oesophageal reflux disease – a century of acid suppression (2006) (28)
Small Intestinal Bacterial Overgrowth in Functional Dyspepsia: A Systematic Review and Meta-Analysis. (2021) (28)
Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome (2019) (27)
Guideline adherence and patient satisfaction in the treatment of inflammatory bowel disorders – an evaluation study (2009) (27)
The role of the microbiome and the use of probiotics in gastrointestinal disorders in adults in the Asia‐Pacific region ‐ background and recommendations of a regional consensus meeting (2017) (26)
International validation of a health‐related quality of life questionnaire in patients with erosive gastro‐oesophageal reflux disease (2009) (26)
Non-Erosive Reflux Disease – Defining the Entity and Delineating the Management (2008) (26)
Epidemiological Trends of Functional Gastrointestinal Disorders (2001) (25)
Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study. (2000) (25)
Mental stress and gastric acid secretion (1990) (25)
Consensus report : clinical trial guidelines for pharmacological treatment of irritable bowel syndrome (2003) (24)
Stress and gastrointestinal motility in animals: a review of the literature (1992) (24)
Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease (2020) (24)
Time-resolved three-dimensional MR imaging of gastric emptying modified by IV administration of erythromycin. (2003) (23)
Clinical trial: the treatment of gastro‐oesophageal reflux disease in primary care – prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg (2009) (23)
Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD (2011) (23)
Zonulin in serum as a biomarker fails to identify the IBS, functional dyspepsia and non-coeliac wheat sensitivity (2019) (23)
Is GLP-1 amide an endogenous antagonist at GLP-1 receptors? (1994) (22)
G protein-coupled receptor kinase 6 controls post-inflammatory visceral hyperalgesia (2009) (22)
Inconsistent symptom clusters for functional gastrointestinal disorders in Asia: is Rome burning? (2018) (22)
Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis (2021) (22)
The management of irritable bowel syndrome: a European, primary and secondary care collaboration (2001) (22)
Diurnal variation of abdominal motor responses to colorectal distension and plasma cortisol levels in rats (2001) (21)
Gastroduodenal “Dysbiosis”: a New Clinical Entity (2018) (21)
Failed Therapy and Directions for the Future in Dyspepsia (2008) (21)
Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 (2021) (20)
Molecular basis of functional gastrointestinal disorders. (2004) (20)
Hypothesis Driven Research and Molecular Mechanisms in Functional Dyspepsia: The Beginning of a Beautiful Friendship in Research and Practice? (2006) (19)
Basics of meta-analysis (2020) (19)
Transdiagnostic internet-delivered cognitive-behaviour therapy (CBT) for adults with functional gastrointestinal disorders (FGID): A feasibility open trial. (2018) (19)
Non-physician endoscopists: A systematic review. (2015) (19)
Recurrent Symptoms after Fundoplication with a Negative pH Study—Recurrent Reflux or Functional Heartburn? (2008) (19)
Disturbed in vitro adrenergic modulation of cytokine production in inflammatory bowel diseases in remission (2007) (18)
Immune Activation in Functional Gastrointestinal Disorders. (2019) (18)
Evidence-based medicine and phytotherapy for functional dyspepsia and irritable bowel syndrome: A systematic analysis of evidence for the herbal preparation Iberogast® (2004) (18)
Association betweenH. pylori, duodenal mechanosensory thresholds, and small intestinal motility in chronic unexplained dyspepsia (1996) (18)
Incidence and prevalence of self‐reported non‐coeliac wheat sensitivity and gluten avoidance in Australia (2020) (18)
Ablation of connexin43 in smooth muscle cells of the mouse intestine: functional insights into physiology and morphology (2006) (18)
Is there a causal link between psychological disorders and functional gastrointestinal disorders? (2020) (17)
The ageing gut: diminished symptom response to a standardized nutrient stimulus (2010) (17)
Undiagnosed pancreatic exocrine insufficiency and chronic pancreatitis in functional GI disorder patients with diarrhea or abdominal pain (2017) (17)
Functional dyspepsia (2016) (17)
Influence of Simethicone Added to the Rinse Water during Colonoscopies on Polyp Detection Rates: Results of an Unintended Cohort Study (2018) (16)
Gastrointestinal problems in airline crew members. (1995) (16)
The impact of H. pylori on healing of reflux esophagitis during treatment with pantoprazole (1998) (16)
Psychogastroenterology: a call for psychological input in Australian gastroenterology clinics (2009) (16)
Association between clinical manifestations of complicated and uncomplicated peptic ulcer and visceral sensory dysfunction (2010) (16)
Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease (2020) (15)
Itopride in the treatment of functional dyspepsia in Chinese patients: a prospective, multicentre, post-marketing observational study. (2011) (15)
A 13‐nation population survey of upper gastrointestinal symptoms: prevalence of symptoms and socioeconomic factors (2011) (14)
H. pylori and functional dyspepsia: increased serum antibodies as an independent risk factor? (2001) (14)
Epigastric symptom response to low FODMAP dietary advice compared with standard dietetic advice in individuals with functional dyspepsia (2021) (14)
Neuroendocrine and blood pressure responses to rectal distensions in individuals with high and low visceral pain sensitivity (2007) (14)
Gastrointestinal sensory function in functional dyspepsia. (1995) (13)
On-demand Treatment of Acute Heartburn With the Antacid Hydrotalcite Compared With Famotidine and Placebo: Randomized Double-blind Cross-over Study (2007) (13)
Host immune response determines visceral hyperalgesia in a rat model of post-inflammatory irritable bowel syndrome (2013) (13)
Esophageal perforation, inflammatory mediastinitis and pseudoaneurysm of the thoracic aorta as potential complications of botulinum toxin injection for achalasia (2015) (13)
Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily. (2010) (13)
IBS: a syndrome or many diseases? (2004) (12)
Is There a Link Between H. Pylori and the Epidemiology of Crohn’s Disease? (2017) (12)
Concomitant Irritable Bowel Syndrome Does Not Influence the Response to Antimicrobial Therapy in Patients with Functional Dyspepsia (2021) (12)
G-protein mediated receptor-cell-coupling as a predictor for the long term response to treatment in patients with functional dyspepsia (2003) (12)
GERD Evaluation: Time for a New Paradigm? (2007) (11)
Management of peptic ulcer bleeding—the roles of proton pump inhibitors and Helicobacter pylori eradication (2004) (11)
Letter: budesonide for functional dyspepsia with duodenal eosinophilia—randomised, double‐blind, placebo‐controlled parallel‐group trial (2021) (11)
IBD: Stress causes flares of IBD—how much evidence is enough? (2011) (11)
Polypharmacy—Time to Get Beyond Numbers (2017) (11)
“It ain't over … till it's over!” Risk‐mitigation strategies for patients with gastrointestinal diseases in the aftermath of the COVID‐19 pandemic (2020) (11)
Liver‐related mortality in countries of the developed world: an ecological study approach to explain the variability (2016) (11)
Serum ferritin and survival of renal transplant recipients: a prospective 10-year cohort study (2003) (10)
T1266 Z-338 Improves Meal-Induced Symptoms in Functional Dyspepsia: A Double-Blind, Randomized, Placebo Controlled Crossover Study (2009) (10)
Functional dyspepsia is associated with lower exercise levels: A population-based study (2020) (10)
Epidemiologie und klinische Phänomenologie viszeraler Schmerzen (2002) (10)
Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease (2019) (10)
Heartburn in primary care: problems below the surface (2004) (10)
H. pylori and Functional Dyspepsia (2001) (10)
Itopride in the Treatment of Functional Dyspepsia in Chinese Patients (2012) (10)
Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches (2019) (10)
Efficacy and Safety Study of Acotiamide (Z-338) in European Patients With Functional Dyspepsia (2011) (9)
Papillomatosis Confined to the Distal Biliary Tract — A Rare Cause of Obstructive Jaundice: Report of a Case (2003) (9)
Defects in NLRP6, autophagy and goblet cell homeostasis are associated with reduced duodenal CRH receptor 2 expression in patients with functional dyspepsia (2022) (9)
Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association (2022) (9)
[Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons]. (1996) (9)
Irritable bowel syndrome and functional dyspepsia: what can epidemiology tell us about etiology? (2018) (8)
Clinical triage for colonoscopy is useful in young women (2015) (8)
Patient-Reported Gastrointestinal Symptoms and the Association With Quality of Life Following Kidney Transplantation (2020) (8)
Reflux disease and Barrett's esophagus. (2003) (8)
Complicated and Uncomplicated Peptic Ulcer Disease: Altered Symptom Response to a Nutrient Challenge Linked to Gastric Motor Dysfunction (2014) (8)
Herbal medicines in functional dyspepsia—Untapped opportunities not without risks (2020) (8)
Improvement of Non-Steroidal Anti-Inflammatory Drug-Induced Gastrointestinal Symptoms during Proton Pump Inhibitor Treatment: Are G-Protein β3 Subunit Genotype, Helicobacter pylori Status, and Environmental Factors Response Modifiers? (2011) (8)
Gastroesophageal reflux disease after diagnostic endoscopy in the clinical setting. (2013) (8)
Accuracy of polyp localization at colonoscopy (2016) (7)
Epithelial cell-derived components induce transforming growth factor-α mRNA expression and epithelial cell proliferation in vitro (2001) (7)
Platelet activating factor receptor acts to limit colitis‐induced liver inflammation (2020) (7)
Sleep disturbances in the irritable bowel syndrome and functional dyspepsia are independent of psychological distress: a population‐based study of 1322 Australians (2021) (7)
[Gastrocolic fistula - a rare cause of cachexia and polyneuropathy]. (2002) (7)
Perception of gastric distension (1995) (7)
Functional Dyspepsia (1993) (7)
[Functional gastrointestinal disorders]. (2006) (7)
Effects of a fixed peppermint oil caraway oil combination (PCC) on symptoms and quality of life in functional dyspepsia (2001) (7)
Tegaserod is effective in the retreatment of irritable bowel syndrome with constipation (IBS-C) (2003) (6)
Potentially avoidable surgery in inflammatory bowel disease: what proportion of patients come to resection without optimal preoperative therapy? A guidelines‐based audit (2012) (6)
[Epidemiology and clinical phenomenology of visceral pain]. (2002) (6)
Panel Discussion – Unresolved Issues (2000) (6)
Evaluation of a Multidisciplinary Integrated Treatment Approach Versus Standard Model of Care for Functional Gastrointestinal Disorders (FGIDS): A Matched Cohort Study (2022) (6)
Cost and time savings from a rapid access model of care using transient elastography to screen and triage patients with chronic Hepatitis C infection (2014) (6)
Pantoprazole 40 Mg (PANTO) Is Superior to Esomeprazole 40 Mg (ESO) in Resolving Sleep Disturbances in GERD Patients: 1015 (2006) (6)
Is Helicobacter pylori a cause of nonulcer dyspepsia. (1996) (6)
Duodenal Eosinophils and Mast Cells in Functional dyspepsia: A Systematic Review and Meta-Analysis of Case-Control Studies. (2022) (6)
A novel treatment for patients with constipation: Dawn of a new age for translational microbiome research? (2018) (6)
Early onset of efficacy in patients with functional and motility-related gastrointestinal disorders (2017) (6)
Does long‐term maintenance therapy with ranitidine affect the natural course of duodenal ulcer disease? (1993) (5)
An Evidence-based Approach Towards Targeted Patient Education to Improve Bowel Preparation for Colonoscopy (2019) (5)
T1253 Does Cognitive-Behavioural Therapy (CBT) Improve Outcomes in Inflammatory Bowel Disease (IBD)? Initial Feasibility Report on a Pilot Randomised Controlled Trial (2010) (5)
Long term effects of anacute chemically induced colitis on the visceromotor response to mechanical colorectal distension (2000) (5)
Ursachen der funktionellen Dyspepsie (1992) (5)
Serotoninergic and non-serotoninergic effects of two tricyclic antidepressants on visceral nociception in a rat model (2009) (5)
Reizdarmsyndrom – Stellenwert der aktuellen Motilitätspharmaka (2001) (4)
146 - Duodenal Mucosa-Associated Microbiota (MAM) and Gastric Emptying: Veillonella in the Duodenal MAM Linked to slow Gastric Emptying (2018) (4)
Clinical efficacy of a standard dose rabeprazole and a high dose omeprazole for the relief of GERD symptoms (2001) (4)
The use of modelling studies to inform planning of health services: case study of rapidly increasing endoscopy services in Australia (2019) (4)
A Role for Primary Care Pharmacists in the Management of Inflammatory Bowel Disease? Lessons from Chronic Disease: A Systematic Review (2020) (4)
Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity (2022) (4)
UEG Week 2016 Poster Presentations (2016) (4)
Significant hepatic fibrosis is associated with increased small intestinal permeability (2013) (4)
M1253 Patients' Satisfaction with Specialist Gastroenterologist Consultation for Irritable Bowel Syndrome (IBS)and Health Care Utilisation: Exploring the Role of Patient Expectations (2009) (4)
Current and Future Approaches for Diagnosing Small Intestinal Dysbiosis in Patients With Symptoms of Functional Dyspepsia (2022) (4)
Use of itopride in functional dyspepsia (2006) (4)
Understanding GERD symptoms in the clinical setting. (2005) (4)
T1329 Oral Carbohydrate and Fat Differentially Modulate Symptoms, Gut Hormones and Antral Area in Functional Dyspepsia (2008) (4)
Does doctors' knowledge of inflammatory bowel disease patients' psychological status affect patients' clinical outcomes: a pilot randomized controlled trial. (2009) (4)
[Diagnostic criteria and therapeutic strategies of abdominal pain syndromes]. (2002) (4)
Alterations to the duodenal microbiota are linked to gastric emptying and symptoms in functional dyspepsia (2022) (4)
Overlap of heartburn, functional dyspepsia, and irritable bowel syndrome in a population sample: Prevalence, temporal stability, and associated comorbidities (2022) (3)
Risk-based decision-making related to preprocedural coronavirus disease 2019 testing in the setting of GI endoscopy: management of risks, evidence, and behavioral health economics (2022) (3)
Are All Symptoms in Patients in IBD Due to Occult Inflammation? (2010) (3)
[Does a single oral dose of famotidine influence the blood alcohol level?]. (2008) (3)
Gastrokolische Fistel als seltene Ursache von Kachexie und Polyneuropathie (2002) (3)
Opportunities of twin research in gastroenterology (2018) (3)
Clinical Conditions Associated With Bacterial Overgrowth (2019) (3)
Role of the duodenal microbiota in functional dyspepsia (2022) (3)
Satisfaction of IBS patients with medical consultations: Role of patients expectations (2007) (3)
Approach to the Patient with Dyspepsia and Related Functional Gastrointestinal Complaints (2009) (3)
[Effect of the prostaglandin E2 analog nocloprost on motility and acid clearance of the tubular esophagus in man]. (1993) (3)
Luminal Clinical (2019) (3)
Therapie der funktionellen Dyspepsie (Reizmagensyndrom) (2001) (3)
Hepatic fibrosis is associated with small intestinal permeability in chronic liver disease due to hepatitis C, hepatitis B and non-alcoholic fatty liver disease, in subjects without ascites. A prospective cohort study using non-invasive techniques (2014) (3)
Abdominaler Schmerz (2005) (3)
Gut Inflammation: More Than a Peripheral Annoyance (2017) (3)
Antibiotic use but not gastrointestinal infection frequently precedes first diagnosis of functional gastrointestinal disorders (2021) (3)
Susceptibility genes and functional gastrointestinal disorders (2005) (3)
Improving the Quality of Bowel Preparation: Rewarding Patients for Success or Intensive Patient Education? (2020) (3)
unctional Gastroduodenal Disorders (2006) (3)
Colonic transit studies with 99mTc-rhenium sulfide colloid in live rats. A preliminary study. (2008) (3)
Small intestinal bacterial overgrowth in inflammatory bowel disease (2022) (3)
Genetics, H. pylori and the development of functional gastrointestinal disorders: A twin study (2003) (3)
Links between celiac disease and small intestinal bacterial overgrowth: A systematic review and meta‐analysis (2022) (3)
An in vitro and clinical dose-finding study of antifoaming effects of simethicone during colonoscopy (2019) (2)
Is a Fundamental Design Change for Gastrointestinal Endoscopes Required? (2020) (2)
Funktionelle Dyspepsie und Reizdarmsyndrom (2005) (2)
The link between meal related symptoms and cytokine release in patients with functional dyspepsia (2006) (2)
Functional dyspepsia (2015) (2)
Tu1058: DUODENAL EOSINOPHILS AND MAST CELLS IN FUNCTIONAL DYSPEPSIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CASECONTROL STUDIES (2022) (2)
Herbal preparations in patients with irritable bowel syndrome: Results of a double-blin, randomized, placebo-controlled multicenter trial (2001) (2)
Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology. (2020) (2)
[Chronic intestinal pseudo-obstruction. Clinical symptomatology and course]. (2001) (2)
S1096 Symptom Relief Assessed By Reflux Questionnaire (Request™): A Superior Clinical Endpoint Compared to Investigator-Assessed Heartburn? (2008) (2)
Validierung eines gastrointestinalen Symptomscores (GIS) zur standardisierten Erfassung dyspeptischer Beschwerden bei Patienten mit funktioneller Dyspepsie (2004) (2)
Intraoperative cholangioscopy in the management of biliary adenomas (2004) (2)
Ganciclovir and lamivudine combination therapy after orthotopic liver transplantation (1998) (2)
Multiple Polypen des Colon mit Gallertkrebs (2)
Effects of Menthacarin on symptoms and quality of life in patients with functional dyspepsia: Result of a 8-week optional placebo controlled follow-up (2016) (2)
Hepatology Clinical (2019) (2)
Sa1957 – Incidence, Prevalence and Risk Factors Associated with Functional Gastrointestinal Disorders: A Longitudinal Cohort Study of 1322 Individuals (2019) (2)
Systematic review and meta-analysis: Prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome (2018) (2)
[Sensory function and functional diseases of the gastrointestinal system]. (2001) (2)
P172 - In what proportion of IBD patients coming to resection surgery was there an opportunity to optimise preoperative care? A one year audit of a tertiary referral hospital (2009) (2)
T1952 Incidence and Risk Factors of Uncomplicated Peptic Ulcer and Bleeding Peptic Ulcer Over a 10-Year Period (2009) (2)
530 Complicated and Uncomplicated Peptic Ulcer Disease: the Altered Symptom Response to the Nutrient Challenge Is Linked to Gastric Motor Function (2008) (2)
Influence of repeated phasic distension on gastric mechanosensory function in subjects (non-patients) with and without functional dyspepsia (1998) (2)
Funktionelle Dyspepsie – eine Verlegenheitsdiagnose? (2006) (2)
Time-resolved three-dimensional MR-Imaging of gastric emptying modified by intravenous application of Erythromycin (2003) (2)
Recombinant human erythropoietin counteracts cisplatin-induced visceral hyperalgesia (2010) (2)
Asia‐Pacific guidelines for managing functional dyspepsia overlapping with other gastrointestinal symptoms (2022) (2)
Patient Positioning Guidelines for Gastrointestinal Endoscopic Procedures (2021) (2)
Funktionelle Magen-Darm-Erkrankungen (2006) (2)
Evidence-Based and Emerging Diet Recommendations for Small Bowel Disorders (2022) (2)
GERDyzer™ Treatment Satisfaction Module: Correlation with Symptom Assessment by ReQuest™-GI (2006) (2)
W1111 Comparative Complexity of Crohn's Disease (CD) Compared to Ulcerative Colitis (UC) in a Metropolitan Hospital Setting. Effects of Gender and Disease Activity (2009) (2)
Mo1544 IS SMALL INTESTINAL DYSBIOSIS (SIBO) RELATED TO IMPROVEMENT OF EPIGASTRIC PAIN, EARLY SATIETY AND POSTPRANDIAL PAIN IN RESPONSE TO ANTIMICROBIAL THERAPY WITH RIFAXIMIN IN PATIENTS WITH FUNCTIONAL GASTROINTESTINAL DISORDERS? (2020) (1)
Bedeutung ösophagokardialer Reflexe für die Auslösung von Brustschmerzen (1999) (1)
Update S3-Leitlinie Intestinale Motilitätsstörungen: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (D (2022) (1)
Echtzeit-MRT zur Bewertung von gastralen Funktionsstörungen (2004) (1)
[Octreotide in intestinal pseudo-obstruction?]. (1992) (1)
The effect of a new synthetic cholinergic compound (Aclatonium Napadisilate) on interdigestive motility and pancreatic function in humans (1989) (1)
[Prevalence, causes and effects of increased iron storage in patients with kidney transplantation]. (1990) (1)
Helicobacter pylori eradication and weight gain: has it opened a Pandora’s box? (2011) (1)
Draft Genome Sequence of Streptococcus salivarius AGIRA0003, Isolated from Functional Gastrointestinal Disorder Duodenal Tissue (2021) (1)
Mo1629 Managing Functional Dyspepsia and IBS: Overlap Is Frequently Unrecognised in Clinical Practice, But Overlap Cases Are More Severely Impacted (2016) (1)
Opiodergic antinociceptive pathways modulate gastric mechanosensory function in healthy subjects (2001) (1)
Su1204 VARIATIONS OF THE MUCOSA ASSOCIATED MICROBIOTA ALONG THE HUMAN GASTROINTESTINAL TRACT IN HEALTH AND INFLAMMATORY BOWEL DISEASE (2020) (1)
Letter: non‐invasive transabdominal stimulation device for the treatment of chronic constipation—proof‐of‐principle study in adults (2022) (1)
463 ALLERGIC-LIKE EFFECTOR MEMORY T HELPER (TH) 2 AND AUTOIMMUNE-LIKE TH17.1 CELL POPULATIONS ARE INCREASED IN THE DUODENUM OF PATIENTS WITH FUNCTIONAL DYSPEPSIA (2021) (1)
Histamine H2 receptor antagonists and blood alcohol levels (1988) (1)
Tu1709 Altered Proximal Small-Intestinal Permeability and Bacterial Translocation in Chronic Liver Disease in Relation to Hepatic Fibrosis and Disease Severity (2016) (1)
Carbon‐based compounds emerging as sparkling diamonds for IBS treatment? (2012) (1)
Su1562 In Patients With Crohn's Disease Functional MRI Reveals an Alteration of Amygdala Function Induced by Anti-TNFa That Is Associated With Positive Self-attribution Biases and Reduced Symptom Response to a Standardised Nutrient Challenge (2016) (1)
Visceral Hyperalgesia and Intestinal Dysmotility Following Infection (2004) (1)
(Post) inflammatory visceral hyperalgesia: don't we believe what we don't see? (2002) (1)
Zhizhu Kuanzhong Capsule in treating patients with functional dyspepsia postprandial distress syndrome: study protocol for a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial (2021) (1)
Functional dyspepsia and irritable bowel syndrome—Treatment effects of artichoke-leaf-extract: A placebo-controlled, randomised, multicenter trial (2003) (1)
Asia-Paci fi c consensus on the management of gastro-oesophageal re fl ux disease : an update focusing on refractory re fl ux disease and Barrett ’ s oesophagus (2016) (1)
Increased small intestinal permeability in chronic liver disease is associated with reduced abundance of Faecalibacterium prausnitzii in the terminal ileum mucosa (2016) (1)
Tu1912 – Weight Loss and Metabolic Improvements One Year After Treatment with a Duodenal-Jejunal Bypass Sleeve (Endobarrier®) (2019) (1)
Quantitative PCR as a novel approach to determine influence of density of bacterial colonization on health and disease (2018) (1)
Anti-TNFA Treatment in Crohn's Disease Reduced GI Symptoms and Alters Motivational Circuitry in the Brain (2017) (1)
article : management of peptic ulcer bleeding — the roles of proton pump inhibitors and Helicobacter pylori eradication (2004) (1)
Cellular Immune Activation and Clinical Manifestation of Functional Dyspepsia (2008) (1)
Is there a link between the pattern of functional abdominal symptoms and disturbances of gastric emptying or the response to a nutrient challenge (2000) (1)
Differential involvement of spinal NMDA, CGRP and NK1 receptors in responses to phasic vs. tonic colorectal distension (2000) (1)
Tu1643 - The Effect of Enteric-Coated Peppermint Oil on the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of the Pooled Clinical Trials Data (2018) (1)
Appropriateness and Diagnostic Yield of Colonoscopy in Young Women (2008) (1)
Mo1582 IS THERE AN ASSOCIATION BETWEEN IMPROVEMENT OF GI SYMPTOMS IN PATIENTS WITH FUNCTIONAL GASTROINTESTINAL DISORDERS AND ALTERATIONS OF CIRCULATING GUT HOMING T CELLS AND PRO-INFLAMMATORY CYTOKINES IN RESPONSE TO A 12 WEEK MULTIDISCIPLINARY INTERVENTION? (2020) (1)
Su1015 The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Use in the Clinical Setting (2016) (1)
Mo1583 - Non-Invasive Medical Device for the Treatment of Chronic Constipation: Proof-of-Principle Study in Adults (2018) (1)
Tu1066: SMALL INTESTINAL BACTERIAL OVERGROWTH IN SYSTEMIC SCLEROSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CASE-CONTROL STUDIES (2022) (1)
A preliminary analysis of the effect Iberogast, Nexium, dual Iberogast + Nexium or dual placebo on symptoms in patients with functional dyspepsia (2011) (1)
Influence of cigarette smoking on the human duodenal mucosa-associated microbiota (2018) (1)
Induction of Meal-related Symptoms as a Novel Mechanism of Action of the Duodenal-Jejunal Bypass Sleeve (2020) (1)
Funktionelle Dyspepsie und funktionelle Ösophaguserkrankungen (2013) (1)
Diurnal variation of abdominal motor responses to colorectal distension in a rat model (2000) (1)
Coping With the Unmet Needs of Gastroenterology and Hepatology Outpatients: A Systematic Approach Towards an Integrated Model of Care in South Australia (2011) (1)
Prevalence of dyspepsia and other GI complaints in patients treated for psychosomatic disorders (1998) (1)
Structured oropharynx, hypopharynx and larynx assessment during routine esophagogastroduodenoscopy improves detection of pre- and early cancerous lesions: a multicenter, comparative study (2021) (1)
Mo1881 Onset of Action and Efficiency of STW 5 in the Clinical Setting in Patients With Functional Dyspepsia and Irritable Bowel Syndrome (2013) (1)
901 Immune Activation Is Linked to Meal Induced Symptoms and Anxiety and Depression in Healthy Subjects (2008) (1)
Sa1052 IN-VITRO EVALUATION OF ANTIFOAMING EFFECTS OF SIMETHICONE: A DOSE-FINDING STUDY (2019) (1)
M1249 Do We Know What Patients Want? the Communication/Understanding Gap Between Patients with Functional Gastrointestinal Disorders (FGIDs) and Gastroenterologists (2009) (1)
[Irritable bowel syndrome]. (2005) (1)
Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study. (2023) (1)
Functional dyspepsia and functional esophageal diseases: Epidemiology and pathophysiology (2013) (1)
Mo1885 A Survey of Treatment of Patients With Functional Dyspepsia in the Routine Clinical Setting (2013) (1)
Tu1844 Symptom Stability and Economic Burden in Patients With Functional Dyspepsia: Observational 12 Month Follow-Up After a Short-Term Clinical Trial (2014) (1)
The duodenal mucosa associated microbiome, visceral sensory function, immune activation and psychological comorbidities in functional gastrointestinal disorders with and without self-reported non-celiac wheat sensitivity (2022) (1)
What Is the Truth? Sleep Disturbance as Assessed by Investigators or a Validated Instrument (ReQuest™) in Patients with GERD: 17 (2007) (1)
A 12-week multidisciplinary integrated treatment approach is superior to standard care for symptom reduction in patients with functional gastrointestinal disorders: A case-control study (2019) (1)
T1427 Sensitization of Visceral Afferents By Immune Cell Supernatants from IBS Patients (2008) (1)
Global endpoints in functional gastrointestinal disease: Authors’ reply (2005) (1)
Efficacy and safety of STW 5 II in patients with functional dyspepsia: results from a double-blind, randomized, multicenter trial (2020) (1)
Mo2071 A Placebo Controlled Randomised Treatment Trial for Functional Dyspepsia Including Post-Treatment Drug Withdraw and Placebo Withdraw Effects (2013) (1)
Di V erences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls (2000) (1)
Physician Perceptions on the Use of Antibiotics and Probiotics in Adults: An International Survey in the Asia-Pacific Area (2021) (1)
T1025 IBS and Outpatient Services: Towards the Development of An Empirical Model of Health Care Utilisation (2008) (1)
Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology. (2020) (1)
How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin? (2022) (1)
Fr071 ANTIBIOTICS FREQUENTLY PRECEDE FIRST DIAGNOSIS OF FUNCTIONAL GASTROINTESTINAL DISORDERS (2021) (1)
The role of mood state and emotion regulation in the discrepancy between gastrointestinal symptom burden recorded prospectively and via recall questionnaire (2021) (1)
Type 2 and type 17 effector cells are increased in the duodenal mucosa but not peripheral blood of patients with functional dyspepsia (2023) (1)
Fr074 OVERLAP BETWEEN HEARTBURN, FUNCTIONAL DYSPEPSIA AND IRRITABLE BOWEL SYNDROME, OCCURS MORE THAN CHANCE AND IMPACTS ON PSYCHOLOGICAL WELLBEING (2021) (1)
Diagnostische Kriterien von und therapeutische Strategien bei Schmerzen des Magen-Darm-Trakts und der Beckenorgane (2002) (1)
Helicobacter pylori, Genetik und die Entwicklung abdomineller Symptome (2015) (0)
Self-Reported Asthma and Food Allergy are Independent Risk Factors for Functional Gastrointestinal Disorders. A Random Population Based Study (2017) (0)
Irritable bowel syndrome, dyspepsia and other chronic disorders of gastrointestinal function (2016) (0)
Der Einfluss einer gestörten viszeralen Motorik und Sensorik auf den Langzeitverlauf bei Patienten mit Funktioneller Dyspepsie (2005) (0)
Mo1633 Prevalence of Undiagnosed Pancreatic Exocrine Insufficiency in Diarrhea-Predominant Irritable Bowel Syndrome (IBS) (2016) (0)
Kolondivertikulose, Divertikulitis und Divertikelblutung (2010) (0)
Sa1859 - Minimal Association Between the Duodenal Mucosa-associated Microbiome and Usual Dietary Intake: A Pilot Study (2018) (0)
Mo1871 A 12 Month Follow-up of Patients Complying With ROME III Criteria for FD: Symptom Stability and Economic Burden (2013) (0)
Fr237 MUCOSAL EFFECTOR T HELPER 17 RESPONSES TO GLUTEN STIMULATION ARE ASSOCIATED WITH GENE EXPRESSION OF TRAV26-2, A GLIADIN-BIASED T CELL RECEPTOR VARIANT IN PATIENTS WITH FUNCTIONAL DYSPEPSIA. (2021) (0)
Cigarette smoking and diversity of the duodenal mucosa associated microbiome (2017) (0)
Sa1675 – The Immediate and Delayed Effects of Disturbed Sleep on Pain and Non-Pain Gastrointestinal Symptoms: Results from an Ecological Momentary Assessment Study (2019) (0)
M1211 Is There Any Association Between Disturbed Gastrointestinal Visceromotor and Sensory Function and Impaired Quality of Life in Functional Dyspepsia? A Population-Based Study. (2009) (0)
Neuroendocrine and cellular immune responses to nutrient challenge in irritable bowel syndrome, ulcerative colitis, and health (2003) (0)
W1732 Hormonal Modulation of Symptom Severity and Visceral Sensitivity in Female Patients with Functional Dyspepsia (2009) (0)
Su1973 - The Duodenal-Jejunal Bypass Sleeve (Endobarrier®) Induces Transient Changes in the Stool Microbiota (2018) (0)
Su1800 Advanced Hepatic Fibrosis Is Associated With Increased Small Intestinal Permeability: A Novel Evaluation Incorporating a Plasma-Based Assay and Transient Elastography (2013) (0)
S1034 Symptoms of Functional Gastrointestinal Disorders (FGIDs) in IBD Patients and the Inter-Relationships of Psychological Co-Morbidity, Quality of Life and Disease Activity (2009) (0)
P117 What is the “Unmet need” in patients with inflammatory bowel disease and is this linked to inflammatory activity? (2013) (0)
Improvements of Liver and Glycaemic Parameters after Duodenal-Jejunal Bypass Sleeve (DJBS) Insertion (2017) (0)
1100 Chronic Hepatitis C Is Associated With Dysbiosis of the Small Intestinal Microbiota and Altered Intestinal Permeability (2016) (0)
Celiac Disease as a risk factor for the manifestation of Crohn's disease (2016) (0)
Cost effectiveness of rapid access to assessment and treatment model of care: Targeted hepatitis C clinics (2013) (0)
The probiotic E. coli Nissle 1917 is a potent modulator of mucosal inflammation and visceral sensory function (2007) (0)
Granulocyte Function in Patients with Functional Gastrointestinal Disorders and Links with Gut Function (2017) (0)
Anti-Cytolethal Distending Toxin B Antibody (Anti-CdtB) Differentiates Functional Dyspepsia From Healthy Controls (2018) (0)
Sa1983 SELF-REPORTED NON-CELIAC WHEAT SENSITIVITY IN PATIENTS WITH CHRONIC UNEXPLAINED (FUNCTIONAL) GASTROINTESTINAL SYMPTOMS: GUT FUNCTION, IMMUNE ACTIVATION AND DUODENAL MUCOSA ASSOCIATED MICROBIOME (2020) (0)
Abstracts of the Scientific Meeting of the Bayliss & Starling Society. Guest Editor: Keith D. Buchanan, Belfast, Northern Ireland (1999) (0)
Mechanisms involved in the development of dyspeptic symptoms during treatment with aspirin (1998) (0)
Interaktionen von Kappa-Opioiden und Neurokinin1-Rezeptor-Agonisten: Viszerale Nozizeption in einem Ratten-Modell (2015) (0)
What is the optimal method for the assessment of visceral mechano-sensory thresholds in humans: Sensory tracking, phasic ramp or random ramp distension? (1998) (0)
Anxiety Predisposes for Impaired Steroid Sensitivity in Patients With Inflammatory and Irritable Bowel Disease (2011) (0)
Somatisation Indirectly Effects the Relationship Between Sleep and Irritable Bowel Syndrome (2017) (0)
Cytotoxic T-lymphocyte antigen-4 haplotypes and T cell activation in irritable bowel syndrome (2007) (0)
Author Index and Subject Index (2001) (0)
Diagnostic yield and healthcare resource utilization of Eesophagogastroduodenoscopy in patients referred for colonoscopy for investigation of positive Fecal Occult Blood Test (FOBT plus ) (2019) (0)
Su1948 Duodenal Microbiota and Response to a Nutrient Challenge in Functional Dyspepsia (2016) (0)
330: EFFICACY AND SAFETY OF STW-5-II IN PATIENTS WITH FUNCTIONAL DYSPEPSIA: RESULTS FROM A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, 8-WEEK MULTICENTER TRIAL INCLUDING A POST-HOC ANALYSIS FOR PATIENTS MEETING FUNCTIONAL DYSPEPSIA ACCORDING TO ROME IV (2022) (0)
A hospital-based, multidisciplinary approach to lifestyle management is effective in patients with non-alcoholic fatty liver disease (2019) (0)
945 – Gluten Avoidance and Self-Reported Non-Celiac Wheat Sensitivity: Incidence and Prevalence from a Longitudinal Cohort Study of 1322 Individuals (2019) (0)
Do antidepressants have an impact on the course of inflammatory bowel disease: South Australian gatroenterologists' perspectives (2006) (0)
Postinflammatory visceral hyperalgesia is linked to disturbed antinociceptive pathways in a rat model (2001) (0)
Abstracts der 17. Jahrestagung (2008) (0)
No pain - No gain: Results of a placebo controlled double-blind 8-week study on the effects of a proprietary kiwifruit preparation (Zyactinase (R)) on IBS symptoms (2016) (0)
Stress induced Visceral Hypersensitivity: Modulation by preceding mucosal Inflammation and role of Neurokinin Receptors (2004) (0)
Unravelling the controversy with small intestinal bacterial overgrowth (2023) (0)
Small Intestinal Bacterial Overgrowth Complicating Gastrointestinal Manifestations of Systemic Sclerosis: A Systematic Review and Meta-analysis (2023) (0)
GERD: How to Have a Better Day (2007) (0)
Mo1665: ADAPTATION AND UTILIZATION OF THE STRUCTURED ASSESSMENT OF GASTROINTESTINAL SYMPTOM SCALE (SAGIS) TO SUPPORT STANDARDIZED ASSESSMENT AND FOLLOW-UP IN CHILDREN AND ADOLESCENTS WITH GASTROINTESTINAL COMPLAINTS (2022) (0)
Correction to: An in vitro and clinical dose-finding study of antifoaming effects of simethicone during colonoscopy (2019) (0)
Tu1059: SMALL INTESTINAL BACTERIAL OVERGROWTH IN CELIAC DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CASE-CONTROL STUDIES (2022) (0)
W1691 Immunologic Function in Patients with Functional Dyspepsia: Are Psychological Disorders of Relevance? (2009) (0)
T1171 Concomitant Symptoms of Functional Gastrointestinal Disorders (FGIDs) in Patients with Inflammatory Bowel Disease (IBD) Are Associated with Decreased Quality of Life (Qol) (2008) (0)
PERSPECTIVE (1942) (0)
Self-reported non-celiac wheat sensitivity (NCWS) in patients with chronic unexplained (functional) gastrointestinal symptoms (2020) (0)
Cytokine Modulation of Visceral Afferents via Cation Channels is Switched in Chronic Visceral Hypersensitivity (2011) (0)
273 – A Multidisciplinary Integrated Treatment Approach is Superior to Standard Care for Functional Gastrointestinal Disorders (FGIDS): A Case-Control Study (2019) (0)
P523 Cyclosporin rescue therapy is as effective as infliximab at preventing colectomy (2014) (0)
Mucosa-associated microbiota and specific peripheral T-cell populations modulate gut-homing integrin a4&b7 (2017) (0)
S1318 STW5 Leads to Changes in Immunologic Response, as Assessed by Cytokine Secretion, in Healthy Controls, but Not Subjects With Irritable Bowel Syndrome (IBS) (2010) (0)
M1809 What Drives Health-Care Utilization in Patients with Functional Dyspepsia (FD) in a Tertiary Referral Center? (2008) (0)
A systematic review of the performance and cost-efficiency of nurse and non-physician endoscopists (2014) (0)
Tu1363: SYMPTOM CLUSTERS OUTSIDE THE ROME IV CONSENSUS CAN BE IDENTIFIED IN BOTH EASTERN AND WESTERN PATIENTS WITH A DISORDER OF GUT-BRAIN INTERACTION: PRELIMINARY RESULTS OF AN ONGOING INTERNATIONAL MULTICENTER STUDY (2022) (0)
Letter: inverse correlation between Helicobacter pylori and obesity – a conclusion too early? Authors' reply (2014) (0)
Abstracts of the International Conference on stress and digestive motility (1989) (0)
Chronic Hepatitis C is Associated with Dysbiosis of the Small Intestinal Microbiota and Altered Intestinal Permeability (2016) (0)
Serum ferritin and survival of renal transplant recipients: a prospective 10‐year cohort study (2003) (0)
Portocaval anastomosis in the cirrhotic rat ?significance of a preoperative treatment for lowering lethality (1989) (0)
M1852 Do Concomitant Functional Dyspepsia and Irritable Bowel Syndrome Influence Changes in Quality of Life in Patients with Gastroesophageal Reflux Symptoms Referred for Endoscopy? - the MAPSOMAL Study (2009) (0)
[Significance of esophagocardiac reflexes for inducing thoracic pain]. (1999) (0)
Su1013 Case-Control Analysis of Risk Factors for Poor Bowel Preparations in Outpatient Cohorts (2016) (0)
Life in the small intestine: the forgotten microbiome? (2017) (0)
Einfluss der Inanspruchnahme ergänzender Behandlung auf die Patientenzufriedenheit–Ergebnisse einer Studie zu chronisch entzündlichen Darmerkrankungen (CED) und dem Reizdarmsyndrom (RDS) im Rahmen des Essener Zirkels (2005) (0)
Translating ourmicrobiome intomedicine Integrating contemporary microbiology with new sequencing technologies will allow us to better understand our microbiome and its relationships with health and disease (2017) (0)
Su1633 Placebo Effects in Functional Dyspepsia: A Preliminary Analysis on Symptoms in an Ongoing Randomized Placebo Controlled Trial (2012) (0)
Immune activation in functional dyspepsia: A result of psychological co-morbidity? (2009) (0)
M1912 Do Socioeconomic Status and Lifestyle Factors Predict Symptomatic Improvement Over 8 Weeks in Patients with Gastroesophageal Reflux Symptoms in the Routine Clinical Setting? - the MAPSOMAL Study (2009) (0)
813: VALUE BASED ASSESSMENT OF SAME DAY UPPER AND LOWER ENDOSCOPY FOR PATIENTS REFERRED FOR COLONOSCOPY WITH A POSITIVE IMMUNOCHEMICAL FECAL OCCULT BLOOD TEST (2022) (0)
Sa1601 - The Immediate Effect of Ibs Symptoms and Pain Appraisals on Mood in Ibs: Results from an Ecological Momentary Assessment Study (2018) (0)
Symptom pattern in patients with functional dyspepsia: Association with anxiety, depression and G-protein (GNB3) genotype (2003) (0)
Delayed gastric emptying determines prognosis in critically ill patients with sepsis (2011) (0)
Hormon regulated symptom fluctuation in female patients with functional dyspepsia (2009) (0)
Distinct Adaptive Immunophenotype in duodenal mucosa but not peripheral blood of patients with functional dyspepsia (2021) (0)
Tu1084 Structured Assessment of Gastrointestinal Symptoms Scale: The Sagis Instrument (2015) (0)
Letter: investigating the intestinal mucosa‐associated microbiota – relevance and potential pitfalls. Authors’ reply (2016) (0)
Is there an association between enteric methane (CH4) production and symptoms in patients with unexplained gastrointestinal (GI) symptoms (2017) (0)
Functional Gastrointestinal Disorders (FGIDs) Patients Benefit from a 12-weeks Multidisciplinary Integrated Treatment Approach to Reduce Gastrointestinal Symptoms, Anxiety and Depressive Symptoms (2019) (0)
Letter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis. (2023) (0)
Su1202 QUANTITATIVE PCR AS A NOVEL APPROACH TO DETERMINE SMALL INTESTINAL BACTERIAL LOAD IN HEALTH AND DISEASE (2020) (0)
Dyspepsia: Treatment Options Directed to Specific Targets (2021) (0)
Limitations of two TCA's serotonergic effects on visceral nociception in a rat model (2007) (0)
S1339 A Double-Blind, Randomized, Cross-Over Study on the Effects of STW5 on Symptoms and Immunologic Function in Patients With Irritable Bowel Syndrome (2010) (0)
T1089 Symptomatic Uncomplicated Peptic Ulcer Disease: True Peptic Ulcer or Functional Dyspepsia? (2010) (0)
A Comparison of Symptom Intensity in Patients with Irritable Bowel Syndrome in Primary and Secondary Care (2004) (0)
Mo1103 STANDARDISED OROPHARYNX, HYPOPHARYNX AND LARYNX ASSESSMENT DURING 1000 CONSECUTIVE ELECTIVE OESOPHAGOGASTRODUODENOSOCOPIES – A PROSPECTIVE MULTICENTRE FEASIBILITY TRIAL (2018) (0)
Tricyclic antidepressant's effects on visceral nociception and its underlying mechanisms (2006) (0)
662 Gastrointestinal T Cell Homing Is Linked to Sepsis Associated Gastroparesis in Mechanically Ventilated ICU Patients (2013) (0)
Patient Factors as Predictors of Bowel Preparation Quality in an Australian Tertiary Hospital (2017) (0)
Asia-Pacific consensus on the management of gastroesophageal reflux disease: Update (Journal of Gastroenterology and Hepatology 22, (8-22) DOI: 10.1111/j.1440-1746.2007.05249.x) (2008) (0)
[Functional dyspepsia - diagnosis of desperation?]. (2006) (0)
Metabolic and nutrition-related effects of a duodenal-jejunal bypass sleeve in patients with obesity and Type II diabetes: Preliminary results of a pilot study (2019) (0)
Mo1118 Beneficial Effect of the Standardised Assessment of Gastrointestinal Symptoms (SAGIS) Instrument on the Time Required to Clinically Assess GI Patients in an Outpatient Environment: A Randomized Study (2016) (0)
Obstipation, Verdauungs- und Motilitätsstörungen – Klinische Symptomatik ist richtungsweisend für Diagnose und Therapie (2009) (0)
Acute and long-term effects of a mucosal inflammation on peripheral neurokinin receptor expression (2003) (0)
#92 Delayed recovery of rectal distension stress-induced increases in circulating CD3−CD16+CD56+ lymphocytes in patients with irritable bowel syndrome (2005) (0)
AKTUELLE DIAGNOSTIK DER DYSPEPSIE (2008) (0)
Su1079: DIABETES MELLITUS IS A RISK FACTOR FOR REPORTING EARLY SATIETY AND DIARRHEA SYMPTOMS AT FOLLOW-UP AFTER ADJUSTING FOR PSYCHOLOGICAL AND LIFESTYLE FACTORS. AN ANALYSIS OF TWO INDEPENDENT PROSPECTIVE LONGITUDINAL POPULATION-BASED STUDIES. (2022) (0)
Evidence for an Association Between Conditions of Immune Dysregulation and Functional Gastrointestinal Disorders. Findings from a Random Population Based Study (2017) (0)
Mo1630 Impact of Symptoms on Daily Activities in Patients With Functional Gastrointestinal Disorders and Organic Gastrointestinal Diseases (2016) (0)
Su1961 - Mass Spectrometric Analysis of Volatile Organic Compounds Produced by Duodenal Microbiota (2018) (0)
Su1977 - Characterization of the Mucosal- and Device-Associated Microbiota Following 48 Weeks Treatment with a Duodenal-Jejunal Bypass Sleeve (Endobarrier®) (2018) (0)
Acoustic radiation force impulse imaging provides accurate assessment of liver fibrosis and is well correlated with transient elastography, biochemical and histological parameters (2013) (0)
Mo1828 Systematic Review of Case Control Studies and an Ecological Study Approach Focussing on Incidence and Prevalence of Crohn's Disease: An Inverse Correlation Between H. Pylori and Crohns Disease (2016) (0)
In vitro adrenergic and glucocorticoid regulation of cytokine production in postinfectious irritable bowel syndrome (2006) (0)
Psychiatric comorbidity in patients with (terminal) functional dyspepsia is not linked to severity or duration of symptoms and utilization of health care ressources (2000) (0)
Modulation of Stress- and Inflammation induced Visceral Hypersensitivity by peripheral Neurokinin 1 Receptors (2005) (0)
Translating our microbiome into medicine (2017) (0)
T2015 Multivariate Analysis of Predictors for Severity of Mucosal Lesions in Patients with GERD Symptoms (Mapsomal): A Clinical, Epidemiological and Endoscopic Survey (2008) (0)
Empirical third line H. pylori eradication therapy: a meta-analysis (2012) (0)
Contents Vol. 80, 2009 (2009) (0)
The Influence of Socioeconomic Status on the Prevalence of Upper Gastrointestinal Symptoms: A 13-Nation Population Survey (2011) (0)
Seroreactivity to Microbial Antigens and Gut‐Homing Immune Responses in Functional Dyspepsia Patients with Postprandial Distress Syndrome (2018) (0)
Sa1002: SOCIAL DETERMINANTS AND PARTICIPATION IN FECAL OCCULT BLOOD TEST BASED COLORECTAL CANCER SCREENING: A QUALITATIVE SYSTEMATIC REVIEW AND META-SYNTHESIS OF BARRIERS IN DISADVANTAGED POPULATIONS (2022) (0)
Su1119: STRAIN-LEVEL FUNCTIONAL AND PHENOTYPIC RESOLUTION OF THE DUODENAL MUCOSA-ASSOCIATED MICROBIOTA IN FUNCTIONAL DYSPEPSIA AND HEALTHY CONTROL SUBJECTS VIA A NOVEL EX VIVO COMBINATION OF MICROBE CULTURE AND METAGENOMIC SEQUENCING (2022) (0)
W1369 Small Bowel Homing T Lymphocytes and Symptom Severity in Patients with Functional Dyspepsia (2008) (0)
The association of immune activation with symptoms and psychiatric comorbidity in irritable bowel syndrome (2006) (0)
52 Symptom Response to a Standardized Nutrient Challenge Test Is Linked to GNB3 C825T (2008) (0)
Is the decrease of H. pylori associated with endemic obesity in the western world (2011) (0)
Hen or egg: is there a link between inflammatory bowel and coeliac disease (2015) (0)
Tu1690 Liver-Related Mortality in Countries of the Developed World: An Ecological Study Approach to Explain the Variability (2016) (0)
T2048 Anxiety Exaggerates the Immune Response to Bacterial Antigen Exposure in Patients With Functional Gastrointestinal Disorders (2010) (0)
Erratum to: The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical Setting (2017) (0)
Is geographic variability of incidence and prevalence of Crohn's Disease linked to Helicobacter pylori? An ecologic study (2014) (0)
Teil I: Ellen Ammann: Ein Leben in Beziehungen (2017) (0)
970 A 13-Nation Population Survey of Upper Gastrointestinal Symptoms: Age and Gender (2009) (0)
Selective redution of persistent visceral hyperalgesia following induction of acute colitis by kappa opiates - a comparative study of different opioidergic subtypes (2006) (0)
Initial Validation of the Structured Assessment of Gastrointestinal Symptoms Scale to Support Standardized Evaluation and Follow-Up in Children and Adolescents with Gastrointestinal Complaints (2022) (0)
Visceral hypersensitivity following induction of chemical colitis is selectively reduced via kappa opiate pathways - a comparative study of different opioidergic subtypes (2007) (0)
Is there an influence of gender on mechanosensory function in patients with functional gastrointestinal disorders or in health (2000) (0)
Role of the connexin CX43 for propulsive motor activity and sensory function in an in-vivo model (2003) (0)
Einfluss von rekombinantem Erythropoietin auf die durch Cisplatin veränderte nozizeptive Schwelle (2008) (0)
IGICS: JGA Keynote Program. The 13th International Gastrointestinal Consensus Symposium (GICS). Gastrointestinal Disease: From Basics to Translational and Clinical Research: Abstracts (2020) (0)
Colon, Rectum and Small Bowel (2008) (0)
Symptom improvement during treatment is linked to alterations of sensory function in functional dyspepsia: A placebo controlled randomised treatment trial (2013) (0)
Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide (2023) (0)
Tu1618 – Patients with Functional Gastrointestinal Disorders (FGIDS) Benefit from a Multidisciplinary Integrated Treatment Approach to Reduce Anxiety and Depressive Symptoms (2019) (0)
Su1976 Endoscopic Treatment of Obesity With a Duodenal-Jejunal Bypass Sleeve: Does Impairment of Fat Absorption Explain Weight Loss? (2016) (0)
Su1334 Does Urgency Categorisation (Triaging) Prevent Delayed Diagnoses and Treatment of Significant Gastric and Colonic Disease (2012) (0)
Mo1534 PREVALENCE OF METHANE POSITIVE SMALL INTESTINAL BACTERIAL OVERGROWTH IN IBS AND IBD: A SYSTEMATIC REVIEW AND METAANALYSIS (2020) (0)
2007 " It doesn ' t do any harm , but patients feel better " : a qualitative exploratory study on gastroenterologists ' perspectives on the role of antidepressants in inflammatory bowel disease (2017) (0)
Routine assessment of gastrointestinal symptom using a validated questionnaire in the clinical setting to assess the probability of organic or functional gastrointestinal diseases (2021) (0)
Role of kappa-opioids and neurokinin 1 receptor interactions on visceral nociception in a rat model (2003) (0)
Sa1338 Do Co-Morbid Mental Disorders Impact Differently on Perceived Symptom Severity in Patients With Gastrointestinal Diseases? A Comparison of Functional Dyspepsia and Intestinal Graft-Versus-Host Disease (2013) (0)
M1905 Symptom Resolution in Uninvestigated Patients with Symptoms of Gastro-Oesophageal Reflux Treated with Rabeprazole or Esomeprazole: A Randomised Trial (2009) (0)
Functional dyspepsia : current management approaches (1995) (0)
Zonulin as a Biomarker to Identify the Irritable Bowel Syndrome (IBS), Functional Dyspepsia (FD), and Non-Celiac Wheat Sensitivity (NCWS) (2018) (0)
In patients with functional dyspepsia, overlapping of dyspepsia subgroups is a marker for severity (2000) (0)
Peroral endoscopic myotomy for achalasia: Predictors of treatment response (2020) (0)
Mo1562 - Atopy and Autoimmune Diseases are Linked to Psychological Distress via the Presence of Functional Gastrointestinal Disorders. A Population-Based Study of 3542 Australians (2018) (0)
Mechanisms of Action for Weight Reduction in Patients Treated with a Duodenal-Jejunal Bypass Sleeve (2018) (0)
Effect of cisapride on visceral sensory thresholds in humans (1998) (0)
Proton Pump Inhibitors, Irritable Bowel Syndrome and Functional Dyspepsia - A Random Population Based Study (2017) (0)
Su1589 - Psychological Distress is Associated with the Perceived Severity of Constipation and Diarrhea (2018) (0)
ORIGINAL CONTRIBUTIONS Nutrition/Obesity Functional Dyspepsia Is Associated With a Greater Symptomatic Response to Fat But Not Carbohydrate, Increased Fasting and Postprandial CCK, (2008) (0)
Sa2068 The Effect of the Probiotic Escherichia coli Nissle 1917 on Symptom Patterns and Immune Response in Patients Suffering From Diarrhoea Predominant Irritable Bowel Syndrome (2012) (0)
IBS: genes versus the environment (2012) (0)
What is the unmet need in patients with inflammatory bowel disease and is this linked to inflammatory activity (2012) (0)
470 Immune Cell Supernatants from IBS Patient Subtypes Differentially Affect Visceral Afferent Mechanosensitivity (2009) (0)
S1026 Inflammatory Bowel Disease Patients and Healthcare Utilization: Gastroenterologists Do Make a Difference! (2009) (0)
Altered Response of Peripheral Blood Mononuclear Cells to Substance P Stimulation in Patients with Irritable Bowel Syndrome (2005) (0)
P0541 : Small intestinal permeability is elevated in chronic viral hepatitis prior to the development of cirrhosis, and is associated with the degree of fibrosis (2015) (0)
Effect of Escherichia coli Nissle 1917 on Post-inflammatory Visceral Sensory Function in a Rat Model (2005) (0)
Basic Science Luminal (2016) (0)
Is the Association Between Psychological Distress and Irritable Bowel Syndrome Acting Indirectly via Early Childhood Microbial Exposure Factors (2017) (0)
Contents Vol. 84, 2011 (2011) (0)
S1016 Psychogastroenterology: A Biopsychosocial Approach to Treating Inflammatory Bowel Disease (IBD) (2010) (0)
W1736 Differences in Visceral Sensation Between Patients with Barrett's Esophagus and Non-Erosive Reflux Disease Assessed By Esophageal Balloon Distension and Acid Perfusion (2009) (0)
From trash to gold: gastrointestinal microbiome research in patients with functional gastrointestinal disorders (2021) (0)
Mo1561 - Understanding the Interrelationships Between Sleep Disturbance, Psychological Distress and Functional Gastrointestinal Disorders. A Population-Based Study of 3542 Australians (2018) (0)
Additional file 2: of The use of modelling studies to inform planning of health services: case study of rapidly increasing endoscopy services in Australia (2019) (0)
Role of Central Kappa Opioid Receptors in Post-inflammatory Visceral Hyperalgesia (2005) (0)
[Change in paradigmas? From functional disorder to inflammation - associated disorder of the funktion activation of the mucosal immune system in irritable bowel syndrome]. (2003) (0)
Characterization of Gut Homing properties of circulating T cells in patients with Irritable Bowel Syndrome (IBS) (2007) (0)
Tu1563: INFLUENCE OF PROTON PUMP INHIBITORS ON THE MUCOSA ASSOCIATED MICROBIOME IN THE SMALL INTESTINE AND COLON (2022) (0)
T1331 Cellular Immune Activation Determines Symptom Severity in Patients with Functional Dyspepsia (2008) (0)
Mo1798 Sampling of the Mucosal Microbiota in the Upper Gastrointestinal Tract: A Comparison of the Novel Brisbane Aseptic Mucosal Sampling Device Versus Standard Biopsy (2015) (0)
Das Paradox des subjektiven Wohlbefindens-ein Gruppenvergleich (2005) (0)
[The value of sucralfate in Helicobacter pylori eradication therapy]. (1997) (0)
Electroencephalographic evidence of unconscious and conscious attentional bias in people with functional gastrointestinal disorders: A pilot study (2021) (0)
W1368 Immune Activation and Clinical Manifestation of Peptic Ulcer Disease (2008) (0)
Upper Gastrointestinal Endoscopy in Subjects with Positive Faecal Occult Blood Test Undergoing Colonoscopy: Systematic Review and Meta-Analysis. (2023) (0)
Neurochemical alterations detected in Irritable Bowel Syndrome using 2D L-COsy (2016) (0)
Factorial analysis-based assessment of the Mucosa Associated Microbiome (2019) (0)
Diabetes mellitus is an independent risk factor for a greater frequency of early satiation and diarrhea at one and three years: Two prospective longitudinal population‐based studies (2022) (0)
Capsaicin sensitive nervous fibers induce transforming growth factor-alpha and-beta expression in the rat colonic mucosa in vivo (2001) (0)
T1172 Psychological Co-Morbidity and Quality of Life (Qol) Vary Between Inflammatory Bowel Disease (IBD) Cohorts in Different Regions and Amongst IBD and Other Chronic Diseases in the One Region (2008) (0)
Persistently altered visceral perception after resection of an esophageal granular cell myoblastoma: a therapeutic concept revisited. (2003) (0)
Subject Index Vol. 80, 2009 (2009) (0)
P113 - Interactions among treatment trends, quality of life and disease activity in inflammatory bowel disease (IBD) (2009) (0)
Repeated local inflammation of the GI tract: Does it influence the development of persistent visceral hyperalgesia? (2003) (0)
[Therapy with pancreatic enzyme preparations]. (1993) (0)
[Irritable bowel syndrome--role of motility inhibitors]. (2001) (0)
[The portacaval anastomosis in the liver cirrhosis model in the rat--significance of special preoperative preparation for decreasing surgical fatalities]. (1989) (0)
334: FUNCTIONAL DYSPEPSIA PATIENTS HAVE IGG ANTIBODIES AGAINST A NOVEL ISOLATE OF STREPTOCOCCUS SALIVARIUS (2022) (0)
[Functional dyspepsia, diagnosis and therapy]. (1997) (0)
Determinación de osmolalidad de formas farmacéuticas líquidas orales (2014) (0)
Mechanisms of FD: what is the role of motor, sensory and inflammatory disorders? (2012) (0)
[Therapy of functional dyspepsia (irritable stomach syndrome]. (2001) (0)
[H. pylori and chronic duodenal ulcer: eradication therapy with ranitidine-antibiotic combination and follow-up of ulcer disease]. (1994) (0)
Announcement and Erratum (1999) (0)
The dose dependent effects of naloxone on postinflammatory visceral hyperalgesia are linked to altered supraspinal kappa opioid receptor expression (2003) (0)
[Clinicopathologic conference. Incidental finding of primary hemochromatosis at an early stage? Differential diagnostic considerations]. (1988) (0)
P011 - Do inflammatory bowel disease (IBD) responders differ from non-responders to a postal questionnaire? Implications for generalizability (2009) (0)
[Chronic pancreatitis]. (1995) (0)
[State-of-the-art diagnosis of dyspepsia]. (1998) (0)
Die Lebensqualität bei chronischen Erkrankungen–funktionelle Dyspepsie vs. chronische Lebererkrankungen (2004) (0)
[Causes of functional dyspepsia]. (1992) (0)
[Y1 receptors mediate inhibitory and stimulatory effects of peptide YY in isolated small intestine and large intestine muscles of the rabbit]. (1993) (0)
Die psychiatrische Komorbidität bestimmt das Inanspruchnahmeverhalten von Patienten mit Funktioneller Dyspepsie (2005) (0)
Existieren Unterschiede zwischen den Subtypen (Rom-III) der Funktionellen Dyspepsie hinsichtlich der gastrointestinalen Motorik oder Sensorik sowie einer veränderten Lebensqualität? (2009) (0)
Letter to the Editor: Oral Vancomycin Versus No Therapy for Pediatric Primary Sclerosing Cholangitis (2021) (0)
Durch „Water-avoidance-Stress“ induzierte viszerale Hypersensitivität wird durch vorherige Schleimhautentzündung moduliert (2015) (0)
GNB3-Polymorphismus und der Langzeitverlauf von Patienten mit therapierefraktären Symptomen einer funktionellen Dyspepsie (2015) (0)
Was bestimmt das Inanspruchnahmeverhalten bei Patienten mit funktioneller Dyspepsie: Symptomintensität, Beeinträchtigung der Lebensqualität oder Persönlichkeitsvariablen? (2004) (0)
Funktionelle Dyspepsie und Reizdarmsyndrom: Besteht ein Zusammenhang zwischen Symptomintensität und gleichzeitigem Auftreten beider Symptomkomplexe? (2016) (0)
Tu1898 – A Comparison of Patients with Unexplained (FUNCTIONAL) Symptoms Or Organic Gastrointestinal (GI) Disease: Symptom Severity, Psychiatric Comorbidities, Gastrointestinal Dysbiosis and Immune Activiation (2019) (0)
Psychological co-morbidity impairs steroid sensitivity in patients with ulcerative colitis (2010) (0)
Kann der Langzeitverlauf einer nicht-erosiven Refluxerkrankung durch eine intensivierte medizinische und psychotherapeutische Behandlung beeinflusst werden? (2006) (0)
Der Essener Zirkel–Initiator einer lokalen Versorgungsepidemiologischen Analyse chronischer Darmerkrankungen in der Primär-, Sekundär- und Tertiärversorgung. Unterschiede zwischen chronisch-entzündlichen Darmerkrankungen und dem Reizdarmsyndrom (2005) (0)
Die Schwere gastroenterologischer und hepatologischer Erkrankungen: ein Vergleich von Patienten mit Leberzirrhose und Funktioneller Dyspepsie (2004) (0)
Chemotherapeutische Versuche bei der experimentellen Bazillen-Dysenterie (1937) (0)
Ein validierter Fragebogen verringert den Zeitaufwand für die gastroenterologische Anamnese in der Ambulanz. Validierung und klinischer Einsatz des Fragebogens zum strukturierten Assessment gastrointestinaler Symptome (SAGIS) (2016) (0)
Tu1196 Gastrointestinal (GI) Symptoms in Patients With Dysphagia Referred for High Resolution Manometry: Presence of Lower GI Symptoms Is a Negative Predictor for Achalasia (2015) (0)
Die chronische intestinale Pseudoobstruktion (2001) (0)
Prädiktoren der allgemeinen und spezifischen gesundheitsbezogenen Lebensqualität bei Patienten mit funktioneller Dyspepsie, Schilddrüsenkarzinompatienten und Blutspendern (2004) (0)
[Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group]. (1995) (0)
Funktion antinozizeptiver opioiderger Bahnen und dyspeptischer Beschwerden unter Behandlung mit Nichtsteroidalen-Antirheumatika (2015) (0)
Echtzeit-MRT zur Bewertung gastraler Motilität mit und ohne pharmakologische Stimuli (2004) (0)
Eine 13-Länderstudie zu Oberbauchbeschwerden: Die Bedeutung von Alter und Geschlecht (2009) (0)
Wirksamkeit von Tegaserod bei der wiederholten Behandlung des obstipationsbetonten Reizdarmsyndroms (2015) (0)
Funktionelle Dyspepsie, Diagnostik und Therapie (1997) (0)
E 14.1 – Funktionelle Dyspepsie (funktionelle Magenbeschwerden) (2007) (0)
Upper GI Hepatobiliary (2008) (0)
Die intensivierte medizinische und psychologische Behandlung ist für den Langzeitverlauf bei therapierefraktären Patienten mit Funktioneller Dyspepsie der konventionellen Therapie überlegen (2005) (0)
Wirksamkeit von Tegaserod bei der dreimonatigen Behandlung des Obstipations- betonten Reizdarmsyndromes (RDS) (2004) (0)
Teil II: Ellen Ammann in ihren Arbeitsfeldern (2017) (0)
Alpha-adrenerge Signalwege modulieren gastrale Wahrnehmungsschwellen (2004) (0)
Seroreactivity to mucosa associated microbiota is associated with T cell gut‐homing in functional dyspepsia patients (2022) (0)
Social Determinants and Participation in Fecal Occult Blood Test Based Colorectal Cancer Screening: A Qualitative Systematic Review and Meta-Synthesis. (2023) (0)
Assoziationen zwischen Symptomen des unteren Gastrointestinaltraktes und Achalasie (2016) (0)
Sa1046 IMPROVING THE QUALITY OF BOWEL PREPARATION: REWARDING PATIENTS FOR SUCESS OR INTENSIVE PATIENT EDUCATION? (2018) (0)
Sa389 SMALL INTESTINAL BACTERIAL OVERGROWTH IN FUNCTIONAL DYSPEPSIA: A SYSTEMATIC REVIEW AND META-ANALYSIS (2021) (0)
Placebo effects in functional dyspepsia: Causes and implications for clinical trials (2023) (0)
Eosinophilic Gastritis and Eosinophilic Duodenitis (2022) (0)
Sa1205: ESOPHAGEAL/NON-ESOPHAGEAL GASTROINTESTINAL SYMPTOM-PATTERNS AND EXTRAINTESTINAL MANIFESTATIONS IN THE DIFFERENT ACHALASIA TYPES BEFORE AND AFTER PERORAL ENDOSCOPIC MYOTOMY (2022) (0)
6. Konzepte der Arzneimitteltherapie (2017) (0)
III. Schlussbetrachtung (2018) (0)
Besteht ein Zusammenhang zwischen einer veränderten viszeromotorischen oder sensorischen Funktion und der Lebensqualität bei Patienten mit funktioneller Dyspepsie (2008) (0)
Laparoscopic fundoplication versus laparoscopic Roux-en-Y gastric bypass for gastro-oesophageal reflux disease in obese patients: protocol for a randomized clinical trial (2022) (0)
Su536 MIXTURES OF LACTOBACILLUS ACIDOPHILUS, LACTOBACILLUS PLANTARUM, AND BIFIDOBACTERIUM LACTIS MITIGATE α-AMYLASE INHIBITION BY EXTRACTS OF NON-GLUTEN WHEAT PROTEINS (2021) (0)
Evaluation of small intestinal bacterial overgrowth. (2023) (0)
Electroencephalographic evidence of unconscious and conscious attentional bias in people with functional gastrointestinal disorders: A pilot study. (2021) (0)
Ellen Ammann - Eine intellektuelle Biographie: Ein Beitrag zur Geschichte der Sozialen Arbeit im Kontext der katholischen Frauenbewegung und des ‘Katholischen Deutschen Frauenbundes’ zu Beginn des 20. Jahrhunderts (2017) (0)
Die dosierungsabhängigen Effekte von Naloxon bei postentzündlichen viszerealen Hyperalgesien stehen im Zusammenhang mit veränderten supraspinalen Kappa-Opioid-Rezeptor-Expressionen (2015) (0)
Einfluss von Enteroplant® auf die basale postinflammatorische viszerale Sensorik im Rattenmodell (2004) (0)
Utilising lipid and, arginine and proline metabolism in blood plasma to differentiate the biochemical expression in functional dyspepsia (FD) and irritable bowel syndrome (IBS) (2022) (0)
Does Psychological Stress contribute to persisting Immune Activation in Irritable Bowel Syndrome (2008) (0)
1415-P: Risk–Benefit Data from the Worldwide EndoBarrier (EB) Registry (2022) (0)
Psychoneuroimmunological Responses to Psychological and Visceral Stress in Irritable Bowel Syndrome (2005) (0)
Quantitative PCR as a novel approach to determine small intestinal bacterial load in health and disease (2020) (0)
Clusters of community-dwelling individuals empirically derived from stool diaries correspond with clinically meaningful outcomes (2021) (0)
Splanchnicotomy lowers portal vein pressure in cirrhotic rats (1989) (0)
Tu1463 A New Simplified Approach for Assessing the Severity of Functional Gastrointestinal Disorders (2012) (0)
Non-invasive biomarkers are superior to clinical measures in predicting hepatic decompensation after liver resection (2014) (0)
BRIEF COMMUNICATION Do We Know What Patients Want? The Doctor-Patient Communication Gap in Functional Gastrointestinal Disorders (2009) (0)
Utilising lipid and, arginine and proline metabolism in blood plasma to differentiate the biochemical expression in functional dyspepsia (FD) and irritable bowel syndrome (IBS) (2022) (0)
Discrepancy between epidemiological data and frequency of diagnosis of dyspepsia and functional dyspepsia in the clinical setting (2003) (0)
[Abdominal pain]. (2005) (0)
W1367 Impaired Steroid Sensitivity of Peripheral Blood Mononuclear Cells in Patients with Irritable Bowel Syndrome (2008) (0)
Anxiety is a risk factor for enhanced immune activation after bacterial antigen exposure in patients with functional gastrointestinal disorders (2010) (0)
Menthacarin for the Treatment of Epigastric Pain Syndrome (EPS) and Postprandial Distress Syndrome (PDS): Data of a placebo-controlled trial revisited (2015) (0)
Tu1476 Assessment of Accuracy of Polyp Localization During Colonoscopy Using Magnetic Endoscope Imaging (2014) (0)
A kiwifruit preparation (Zyactinase (R)) improves symptoms in irritable bowel syndrome (2016) (0)
Augmentation of Meal-Related Symptoms following Placement of Duodenal-Jejunal Bypass Sleeve is a Potential Mechanism of Action Inducing Weight Loss (2017) (0)
Su1596 - Categorisation of Patients with Dyspeptic Symptoms Utilising Rome III and Rome IV or Symptom Impact as Assessed with the Validated Structured Assessment of Gastrointestinal Symptoms (SAGIS) Instrument (2018) (0)
Tu1590 - Dietary Intake in Functional Dyspepsia is not Different to Controls or Associated with Symptom Severity (2018) (0)
Development and Validation of a Patient-Reported Experience Measure for Gastrointestinal Endoscopy (2022) (0)
Mo1117 Increase of Demand for Endoscopic Services: A Survey of the Public Sector in Queensland Australia (2013) (0)
Eeffects of simethicone on gastric emptying and mechanosensory function in humans (2000) (0)
IsHelicobacter pylori a cause of nonucler dyspepsia? (2005) (0)
Editorial: the burden of chronic liver disease – an ecological method sees the wood for the trees. Authors’ reply (2016) (0)
Constipation, digestive disorders and disturbed motility - Clinical patterns of symptoms are important signposts for diagnosis and therapy (2009) (0)
Functional gastrointestinal diseases: solution for the therapeutic dilemma (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gerald J. Holtmann?

Gerald J. Holtmann is affiliated with the following schools:

University of Queensland
Stanford University
University of Adelaide

Gerald J. Holtmann's Academic­Influence.com Rankings

Why Is Gerald J. Holtmann Influential?

Gerald J. Holtmann's Published Works

Published Works

What Schools Are Affiliated With Gerald J. Holtmann?

Gerald J. Holtmann's AcademicInfluence.com Rankings